Cognizant shares are rebounding as the IT services firm leverages its Anthropic partnership to capture AI demand, earning a Moderate Buy consensus from analysts despite broader sector headwinds.
Cognizant is the primary subject, with a recent 24.5% three-month surge, a Morgan Stanley price-target raise, and a Moderate Buy consensus indicating a positive outlook.
IBM is mentioned as a dividend-paying rival that has also struggled, with a 16.2% year-to-date decline and 3.1% drop over the past 52 weeks.
The First Trust Dividend Strength ETF is used as a benchmark for comparing Cognizant's performance, with no inherent bullish or bearish implication.
Cognizant Technology Solutions is showing renewed momentum, surging 24.5% over the last three months as the firm pivots toward generative AI. Despite a challenging year marked by a 23.8% year-to-date decline, Morgan Stanley recently raised its price target to $51, citing the company's expanded partnership with Anthropic and its potential to capture growing demand for applied AI services.
Cognizant is aggressively integrating generative AI into its platforms and client projects, notably through an expanded partnership with Anthropic to utilize the Claude AI model.
Analysts maintain a Moderate Buy consensus on CTSH, with a street-high price target of $82, suggesting significant upside potential from current levels.